Visualitza per autor "FELIP, ENRIQUETA"
Ara mostrant els elements 1-20 d 36
-
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A pragmatic guide for management of adverse events associated with lorlatinib
Liu, Geoffrey; Stratmann, Jan; Ou, Sai-Hong; Mok, Tony; MAZIERES, JULIEN; Bauer, Todd; FELIP, ENRIQUETA (Elsevier, 2024-03-14) -
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Wang, Jie F.; Wang, Yan; Lee, Se-hoon; Melosky, Barbara; SHIH, JIN-YUAN; PASSARO, ANTONIO; FELIP, ENRIQUETA (Elsevier, 2024-01) -
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1–Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial
Westeel, Virginie; ÖZGÜROGLU, MUSTAFA; Reck, Martin; Barlesi, Fabrice; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Elsevier, 2024-02) -
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Cho, Byoung Chul; Lee, Jong Seok; Wu, Y. L.; Çiçin, Irfan; Ahn, Myung-Ju; cobo, manuel; FELIP, ENRIQUETA (Elsevier, 2023-12) -
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors
Barlesi, Fabrice; Isambert, Nicolas; Lee, Dae Ho; Peguero, Julio; FELIP, ENRIQUETA; Cho, Byoung Chul (Oxford University Press, 2023-03) -
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782
Bar, Jair; Szalai, Zsuzsanna; Esteban, Emilio; Rodriguez-Abreu, Delvys; Ponce Aix, Santiago; FELIP, ENRIQUETA (Elsevier, 2024-02-17) -
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
Linardou, Helena; Adjei, A. A.; Bajpai, J.; Banerjee, Susana; Berghoff, Anna Sophie; Cerqueira Mathias, C.; GARRALDA, Elena; FELIP, ENRIQUETA (Elsevier, 2023-04) -
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Yang, James Chih-Hsin; Jänne, Pasi A.; Ramalingam, Suresh; Kim, Tae Min; Riely, Gregory; FELIP, ENRIQUETA; Zhou, Caicun (Taylor & Francis, 2023) -
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
Zhou, Caicun; Srivastava, Minu K; Xu, Hao; Wakelee, Heather; altorki, nasser; FELIP, ENRIQUETA (BMJ, 2023-10) -
Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
Pardo Aranda, Nuria; Martinez Marti, Alexandre; Assaf-Pastrana, Juan David; cedres, susana; Valdivia Bustamante, Augusto; Iranzo, Patricia; Callejo, Ana; NAVARRO, ALEJANDRO; FELIP, ENRIQUETA (MDPI, 2023-12-10) -
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
Carbonell, Caterina; Frigola Rissech, Joan; Pardo Aranda, Nuria; Callejo, Ana; Valdivia Bustamante, Augusto; Priano, Ilaria; Martínez Marti, Alexandre; Lenza, Laura; Soleda, Mireia; Gonzalo Ruiz, Javier; Amat Ferrer, Ramon; Iranzo, Patricia; cedres, susana; NAVARRO, ALEJANDRO; Vivancos, Ana; FELIP, ENRIQUETA (Wiley, 2023-05) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
PASSARO, ANTONIO; Addeo, Alfredo; von Garnier, Christophe; Blackhall, Fiona; PLANCHARD, DAVID; FELIP, ENRIQUETA (BMJ, 2020-06-23) -
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer
Chen, Joseph; bearz, alessandra; Kim, Dong-Wan; Mamdani, Hirva; Bauman, J. R.; chiari, rita; FELIP, ENRIQUETA (Springer, 2024-02) -
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
Serna, Garazi; Gonzalez Medina, Alberto; Assaf Pastrana, Juan David; Pardo Aranda, Nuria; Martinez Marti, Alexandre; Priano, Ilaria; Guardia, Xavier; Navarro Garces, Victor; cedres, susana; Valdivia Bustamante, Augusto; Iranzo, Patricia; Callejo, Ana; NAVARRO, ALEJANDRO; fasani, roberta; Gonzalo Ruiz, Javier; Carbonell, Caterina; Frigola Rissech, Joan; Amat Ferrer, Ramon; Vivancos, Ana; Nuciforo, Paolo; FELIP, ENRIQUETA; Dienstmann, Rodrigo (MDPI, 2023-07-14) -
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
Paz-Ares, Luis; Bennouna, Jaafar; Schenker, Michael; Cheng, Ying; FELIP, ENRIQUETA; Cobo, Manuel; Ciuleanu, Tudor Eliade (Elsevier, 2023-02) -
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
Carbone, David; Ciuleanu, Tudor Eliade; Bordenave, Stéphanie; Juan-Vidal, Oscar; Schenker, Michael; cobo, manuel; FELIP, ENRIQUETA (BMJ, 2024-02) -
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
yu, helena; Goto, Yasushi; Hayashi, Hidetoshi; FELIP, ENRIQUETA; Yang, James Chih-Hsin; Reck, Martin (American Society of Clinical Oncology, 2023-12-10) -
HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC
Yu, Helena A; Hayashi, Hidetoshi; Goto, Yasushi; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-06) -
IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications
Burotto, Mauricio; Zvirbule, Z.; Mochalova, A.; Runglodvatana, Y.; Herraez-Baranda, L.; Liu, S.N.; FELIP, ENRIQUETA (Elsevier, 2023-08)